chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented 2 days after second vaccine with myopericarditis as per sxs (pleuritic cp, positional, etc), troponin i to 2.93, and diffuse st elevations and pr depression. Sxs started a few hours after 2nd dose.  Waiting on echo. Don't need cardiac mri, pretty solid dx.
Patient received vaccines and then was asked to have a seat for 15minutes after receiving vaccines to watch for any kind of reaction.  After a couples of minutes they passed out and the pharmacist immediately went out there to see if they were alright.  They had already regained consciousness and stated they have passed out in the past 3 weeks.  They believed it was related to anxiety from getting vaccines.  They stayed for another 15minutes and then someone drove them home.  They confirmed they were feeling better and were okay.
Patient experienced fever (T max of 102.4), transient strabismus, and drowsiness several hours after administration of vaccines.  Patient was admitted to hospital and work-up was done to rule out sepsis. Discharge summary information states post vaccine complecation. msv
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 06-AUG-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVls 10SDV" and lot number J011998 with expiration date of 12-FEB-2015 (route of administration was unknown), which was stored at -0.55 Celsius Degrees for 32 hours, 0 Celsius Degrees for 152 hours, 0.55 Celsius Degrees for 200 hours and 1.11 Celsius Degrees for 176 hours. The type of excursion was refrigerator and the vaccine status in excursion. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
4 days ago pt received Tdap (L) deltoid - day after developed red and swelling about 4-5 cm improved but not resolved on day 4.
Pt recvd vax 1130AM & started feeling hot around 230PM; given APAP drops; started w/sz activity between 7AM & 8PM lasting 1 1/2 to 2 hrs; mom notified MD; child admitted to hosp; pt is irritable but no addl sxs;
tested positive on Day 11 with a resurgence of same symptoms I'd had initially; COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 27Feb2021 as dose 2, single (Lot number: EN6198), in left arm, on 04Oct2021 as dose 3, single (Lot number: FF2089), in left arm and on 07Mar2022 as dose 4 (booster), single (Lot number: FE9895) at the age of 71 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "autoimmune/stent" (unspecified if ongoing), notes: autoimmune/stent; "autoimmune/stent" (unspecified if ongoing), notes: autoimmune/stent. The patient's concomitant medications were not reported. Past drug history included: Statins, reaction(s): "Known allergies: Statins". The following information was reported: VACCINATION FAILURE (medically significant) with onset Jul2022, outcome "not recovered", COVID-19 (medically significant) with onset Jul2022, outcome "recovered" and all described as "COVID-19 treatment"; DISEASE RECURRENCE (medically significant) with onset 06Aug2022, outcome "not recovered", described as "tested positive on Day 11 with a resurgence of same symptoms I'd had initially". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2022) Positive, notes: Day 1 after testing positive; (06Aug2022) Positive, notes: tested positive on Day 11; (Aug2022) Negative, notes: I tested negative on Days 7-10. Therapeutic measures were taken as a result of covid-19. Therapeutic measures were not taken as a result of disease recurrence.  Additional information: Day 1 after testing positive, patient began to take paxlovid and completed the course in 5 days. She tested negative on Days 7-10 and then, tested positive on Day 11 with a resurgence of same symptoms she had had initially. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Client was given Pfizer\BioNTech vaccine for a second dose after a Moderna COVID vaccine first dose., given on 4/29/2021.
covid-like symptoms; Stiff sore arm; Stiff sore arm/ tired sore legs; extreme fatigue; loss of appetite; Feverish; This is a spontaneous report from a contactable consumer or other non hcp.  A 47-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EP6955), via an unspecified route of administration on 20Mar2021 as unknown, single dose for covid-19 immunization. Medical history included covid-19 and allergies to Latex, shellfish and fruit. The patient's concomitant medications were not reported. On 21Mar2021, the patient experienced Covid-like symptoms, stiff sore arm, stiff sore arm/ tired sore legs, extreme fatigue, loss of appetite and feverish. Events were not treated. The patient underwent lab tests and procedures which included SARS-CoV-2 antibody test was unknown. The outcome for all events was unknown.  No follow-up attempts are possible. No further information is expected.
Moderna COVID-19 Vaccine EUA Started with a headache around 9pm. Severe arm pain around injection site. Body chills and then body sweats. Restless sleep. By 6am still had a headache and nauseous. Slept until 11am, awoke with a severe headache and light sensitivity and some nausea. Slept from noon until 3pm and had a slight headache. Headache has been off and on and is present but manageable at time of this report.
Patient presented to clinic for a Moderna booster and received  a full dose (.5ml) Moderna.  RN attempted to reach patient via phone but was unsuccessful.  A voice message was left notifying patient of administration error.
was told by occupational health that rash reporting was mandatory.  Rash noted over entire trunk and all extremities, sparing head, hands, and feet
About 3-5 minutes after vaccination, mother told vaccinator that patient was feeling nauseous.  Patient was up and walking at the time. Patient assisted in a chair into reclining position until nausea subsided.  Pt did not pass out, did not fall, and did not vomit.  Patient spoke with staff throughout event and she reported nausea subsided within 2-3 minutes, no other effects noted or reported.
I began to have moderate to severe hand joint pain and stiffness a few days after my first Pfizer vaccine dose. Joint pain in my knees and lower back followed. The pain slowly started to decrease after a few weeks, but became significant again shortly after my second Pfizer dose. I had significant pain and stiffness in my hand joints. The pain slightly decreased, but has now progressively gotten worse.
Redness, bump, soreness, itching at injection site, noticed 8/27/16 in the evening. Patient took Benadryl on 8/28/16. Area very sore to the touch until 8/29/2016 in the morning. Large red area around injection site (approximately 2in x6in) on 8/29/16 at 12:00pm.
This case was reported by a pharmacist via call center representative and described the occurrence of laceration of finger in a 31-year-old female patient who intended to administer the Shingrix (batch number B9739, expiry date 22nd November 2020) and (batch number D3L5G, expiry date 22nd November 2020) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, immediately after receiving Shingrix, the patient experienced laceration of finger and pharmaceutical product complaint. On an unknown date, the outcome of the laceration of finger and pharmaceutical product complaint were unknown. It was unknown if the reporter considered the laceration of finger to be related to Shingrix. Additional information reported as follows: The reporter would not provide her date of birth. The reporter went to prepare Shingrix for administration. She pulled out a vial of the adjuvant suspension and cut her finger because the vial was broken. The base of the vial was broken off. After inspection of the box it was noted there was one other vial that was missing its base with a crack running up the side. No damage was noted to the blister tray and carton. The evidence of leakage was visible at the bottom of the carton. The glass pieces were visible in the carton. The product was stored in a vaccine only refrigerator on the top shelf. No product was present in the vials. The product was not administered to a consumer. The pharmacy would email picture of defect to GlaxoSmithKline and mail back broken vials. The credit request template was completed to arrange credit.
Narrative: Patient received Moderna covid at groccery store on 7/26/2021 therefore no information related to the product available to reporter. Patient sought care at urgent care however had prescribed medications to treat allergic reaction filled at the clinic.
Left arm localized induration within 5 minutes of PNEUMOVAX. No shortness of breath, itching or redness. Improving prior to discharge 12:54 pm 5/24/16.
The pt experienced induration, erythema, swelling, tenderness, left deltoid muscle pain, posterior thighs with spasm, fever, headache within 24 hours post injection. lasted 5 days.
After the 1st injection I started feeling a little nauseous for the rest of that day and the following.  24 hrs. after the vaccine I also felt extreme fatigue that required me to lay down and sleep for about an hour
Pt recieved four shots right arm (Meningococcal, TDaP, MMR, and Varicella). Had Hyperimmune response with shaking, chills, and temp of 100.6.  Pt refused IV fluids.  Brought back to the clinic and found to have a temp of 103.1 and positive orthostasis.  Given 1 gm of IM Rocephin, medrol dose pack, prn tylenol, po bactrim, cool compresses, quarters for 24 hours.  Pt stated he feel better, but still has mild fatigue and chills, but temp improved to 99.3.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-AUG-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Pale, dizzy and lightheaded immediatiately after shot. Walked out after 25 minutes to car.
Developed cold urticaria approximately 4 weeks after flu vaccine. I have no allergies and all blood work was negative. No other underlining disease or cause was found. I had never had the flu vaccine and that was the only thing different prior to onset of symptoms.
pt recv vax & exp rt arm pain radiating to axilla & breast, swollen & gave neck glands;
swelling up and down her arm; itchiness in her arm; heat in her arm; fever in her arm; moderate site reaction; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling up and down her arm), PRURITUS (itchiness in her arm), FEELING HOT (heat in her arm), VACCINATION SITE REACTION (moderate site reaction) and PYREXIA (fever in her arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE REACTION (moderate site reaction). On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (swelling up and down her arm), PRURITUS (itchiness in her arm), FEELING HOT (heat in her arm) and PYREXIA (fever in her arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (swelling up and down her arm), PRURITUS (itchiness in her arm), FEELING HOT (heat in her arm), VACCINATION SITE REACTION (moderate site reaction) and PYREXIA (fever in her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was provided by the reporter Other treatment information: ice   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow up document is received on 08-JUN-2021 and it is NNI
SWOLLEN  ARMPIT LYMPH NODE ON LEFT SIDE REPORTED TO MY PRIMARY CARE PHYSICIAN.
Anaphylaxis happened within 12 minutes. I was administered epinephrine at the vaccine site, as well as in the ambulance. FURTHERMORE I was administered DiphenhydrAMINE, Famotidine, solu-MEDROL at the Emergency Department. Those are just a few of what I received. When I was finally discharged I was sent home with 2 epi-pens and a 4 day  dosing of Prednisone.
My fever started on the day of vaccination like 100.4 F.  In the early morning next day, it went up to. 102.7 and it stayed for all day.  I even sent an email to to my doctor?s office in the afternoon, - at that time the temp was like 102.2 or so.  But it shot up again in the night.  The fever continued on Friday and I still have chills on Saturday I.e. March 27th 2021 and as I write this.  I also felt nautica first two days.  I have been having headaches  also. I was diagnosed with slow heart rate I.e. 43 beats per minute (I forgot to put this in the long term conditions).  I am worried about the second dose as I reading it is the second dose that causes fever in people, not the 1st dose.  I hope I recover over the weekend.
Suspected vaccination failure; Still had a moderate to severe case; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient had the shot and still had a moderate to severe case of shingles. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not reported.
Initial Adverse reactions lasted until October: Lymph nodes swollen in left arm, chills, night sweats and terrors, tingling in neck and arms, numbness in arms, nauseas, stomach upset and cramping, felt faint, mental confusion, loss of energy, shooting heart pains, poor coordination drop things or reach and miss.  Treatment - rested as much as I could, took vitamin C and D3, zinc, prebiotics, probiotics, excercise, included more vegetables in diet Outcome - still have tingling and numbness in arms, have hard time concentrating for long periods
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  COAGULOPATHY, UNSPECIFIED TYPE PERIPHERAL NEUROPATHY
Persistent pain and limited range of motion in arm where the vaccine was administered. Patient was advised on ice/Voltaren gel/range of motion exercises. She declined physical therapy
Received vaccination on 12/22/20 no adverse reaction until 12/25 when a small rash began to appear on my left elbow. Rash continued to spread to left forearm and the entire right arm beginning on 12/26. 12/27 rash spread to thighs and one calf. 12/29 rash began to spread up both flanks and chest.
Pt's mother, called this RN at 12:15pm and stated that daughter's left arm from shoulder to elbow is red, swollen,hot to the touch and the skin looked "stretched".  Instructed her to take child to ER.  (pt uninsured.)
Severe pain - required narcotics moderate swelling, warmth, erythema fever 102.
Received Pfizer vaccines on 12/22/20, 1/18/21; tested positive for COVID-19 by PCR on 5/26/21, patient was asymptomatic and tested due to upcoming appts at Medical Facility.
This spontaneous report was received from a Licensed Practical Nurse referring to unspecified multiple patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with a dose of PROQUAD lot #: M044020, expiration date on 01-MAY-2018 (strength, dose number and anatomical location were not provided) for prophylaxis. Concomitant therapies included sterile diluent (manufacturer unknown. It was reported that the dose of PROQUAD was improperly stored at 6 °F to 14 °F (10 °F- 4 cycles) for 4 hours 49 minutes. This excursion was detected due to a digital data logger. No adverse effect was reported. This is one of two reports received from the same reporter. Additional information is not expected, since no consent to contact the reporter was provided. Sender's Comments: US-009507513-1706USA006813.
at 3 PM blood press. dropped to 101/60 at store. At 3:30 PM at home had trouble breathing and my heart was beating fast. Then I go sharp pain at the top of my stomach. Then I knew I was having a allergic reaction to the Flu shot. I went back to the doctors office. (back of page). Have to ask my doctor.
I was having frequent urination, burning while urinating, lower belly pain. I had this for about 6 days before I went to the doctor. She tested my urine and found that I had a Urinary Tract Infection. I was prescribed nitrofurantoin, and fluconazole. I am feeling much better after taking the medication.
Case number PHEH2016US029281, is an initial spontaneous report received from a nurse on 07 Nov 2016. This report refers to a 40 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUCELVAX Quadrivalent (batch number: not reported) at a dose of 0.5 ml, intramuscularly following temperature excursion at 52 Fahrenheit for 01 hour on 18 Oct 2016. Second temperature excursion occurred on 23 Oct 2016, dropped low 06 times to 34 Fahrenheit and lasted 30 minutes each time. Third temperature excursion occurred on 02 Nov 2016, down to 32.2 Fahrenheit three times over the course of 12 hours. Vaccine had been administered. It was unknown if vaccine was frozen. Nurse did not know which lot was given to which patient. No adverse event was reported following this administration error.
Vaccine administered beyond Expiration date. However, per Moderna- all vaccines met viability requirements.  Completing VAERS per RA requirements.
Asthma that started the day after injection and lasted until  4 days after the second shot.
Narrative:  On March 24, 2921, a 38yo male was reported as prior Covid-19 positive, presented to the Emergency Department, with dry cough, Fever and shortness of breath. The ED objective note included "he received first dose of Covid-19 vaccine on March 16, 2021: exposed to a soldier with Covid and arrived from another state that Friday (March 19, 2021)" No record of Covid-19 vaccination at the Medical Center and no other prior medical history He was reported with a historical Moderna Covid - 19 vaccine induced adverse reaction of Cough, SOB and night sweat but the Unit's Clinical pharmacist He was placed on cardiac monitor, Covid - 19 Swabbed, Chest X-ray, VBG were done and placed on Oxygen at 2L/min nasal cannula initially the High Flow oxygen 30L/min - 100% saturation He was admitted to Critical care - Chest x- ray showed bilateral infiltration consistent with Covid Pneumonia , BP =118/71 and EKG showed sinus Tachycardia. He received dexamethasone 6mg iv push and Tylenol 650mg oral , oxygen was weaned to room air and continued to have O2 sat in mid 90s., was also started on Remdesivir iv The patient continued to improve and was discharged with on March 28, 2021 D/C instructions included quarantining for next 5 days, to practice social distancing and to take all contact precautions per CDC
Itchy rash, warm skin, bright pink about 3 inches square at injection site.  Did not occur until 26 days after injection.
pt started feeling cold and clammy with numbness in left arm and legs; mom states that this is a normal reaction after blood draws or any injections; patient didn't reveal this when screening questions were asked. gave pt water and wash cloth to use and checked bp; BP was 107/75 with a pulse of 57; observed pt for 30 minutes and pt expressed no more symptoms and feeling much better, refused EMS and Mom stated she was a trauma nurse and didn't feel need for further intervention; pt left pharmacy after 40 minutes post immunization
This spontaneous report was received from a Nurse Practitioner, referring to a 16 year old female patient. The patient's medical history and concurrent conditions were not reported. On 27-AUG-2015, the patient was vaccinated with an expired dose of (Oka/Merck) VARIVAX lot # J007350, expiration date 13-JUN-2015 (dose and route were not reported). No concomitant therapies were reported. No adverse effect reported. It was unknown if the patient sought medical attention. No product quality complaint was involved. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "known allergies: Dust Mites" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing); "known allergies: Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient took Paxlovid for treatment of event from Mar2023 to Apr2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.